Suchergebnisse - "Bani-Sadr, Firouze"

PubPharm (7)

1

Response to anti-HCV therapy in HIV-HCV-coinfected patients : does the lipid profile really have an effect?

enthalten in: Antiviral therapy | 2010

von Petit, J. | Carrat, F. | Duong, M. | +6

2

Prevalence and impact of GBV-C, SEN-V and HBV occult infections in HIV-HCV co-infected patients on HCV therapy

enthalten in: Journal of hepatology | 2008

von Piroth, L. | Carrat, F. | Larrat, S. | +9

3

Serum alpha-fetoprotein predicts virologic response to hepatitis C treatment in HIV coinfected patients

enthalten in: AIDS (London, England) | 2008

von Carrat, F. | Bedossa, P. | Lunel-Fabiani, F. | +8

4

Reactivation of hepatitis B virus replication during peginterferon-ribavirin therapy in an HIV/hepatitis C virus-co-infected patient with isolated anti-hepatitis B core antibodies

enthalten in: AIDS (London, England) | 2007

von Chakvetadze, C. | Bani-Sadr, F. | Le Pendeven, C. | +3

5

Spontaneous hepatic decompensation in patients coinfected with HIV and hepatitis C virus during interferon-ribavirin combination treatment

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2005

von Bani-Sadr, F. | Carrat, F. | Rosenthal, E. | +10

6

Risk factors for symptomatic mitochondrial toxicity in HIV/hepatitis C virus-coinfected patients during interferon plus ribavirin-based therapy

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2005

von Bani-Sadr, F. | Carrat, F. | Pol, S. | +12

7

Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients : a randomized controlled trial

enthalten in: JAMA | 2004

von Carrat, F. | Bani-Sadr, F. | Pol, S. | +12

CommentIn: JAMA. 2004 Dec 15;292(23):2909-13. - PMID 15598923

1
[1]